title: Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
abstract: Voriconazole is a promising azole effective against a variety of fungi, including yeasts. In this study, we tested in vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against some ATCC and reference strains and 250 clinical yeast isolates. We also evaluated the effect of time of reading on MIC results. Voriconazole was the most active agent against Candida and Trichosporon isolates, including the putatively fluconazole-resistant C. krusei (MIC(90) 0.25 microg/ml) and C. glabrata (MIC(90) 0.5 microg/ml). Amphotericin B MICs were scattered in a considerably narrow range in both RPMI 1640 and Antibiotic Medium 3. MICs at 24 hours and 48 hours were similar in general for all antifungals tested. The highest percentage of strains that showed 24-hour and 48-hour MICs within +/-1-log(2) dilution was observed for amphotericin B tested in RPMI (99%), and the lowest for amphotericin B tested in Antibiotic Medium 3 (80%). In conclusion, voriconazole is very effective against a wide spectrum of Candida species and 24-hour readings could substitute 48-hour MIC evaluation.
authors.affiliation: Section of Infectious Diseases, Department of MedicineHacettepe University School of Medicine, 06100, Ankara, Turkey. ouzun@hacettepe.edu.tr
authors.forename: O
authors.initials: O
authors.lastname: Uzun
authors.forename: S
authors.initials: S
authors.lastname: Arikan
authors.forename: S
authors.initials: S
authors.lastname: Kocagöz
authors.forename: B
authors.initials: B
authors.lastname: Sancak
authors.forename: S
authors.initials: S
authors.lastname: Unal
mesh_terms: D000666:Amphotericin B / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects* / Q000302:isolation & purification; D002177:Candidiasis / Q000382:microbiology; D015725:Fluconazole / Q000494:pharmacology*; D006785:Hospitals, University; D006801:Humans; D017964:Itraconazole / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D009181:Mycoses / Q000382:microbiology; D011743:Pyrimidines / Q000494:pharmacology*; D012015:Reference Standards; D013997:Time Factors; D014230:Triazoles / Q000494:pharmacology*; D014250:Trichosporon / Q000187:drug effects / Q000302:isolation & purification; D014421:Turkey; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole; D065819:Voriconazole